Silab says it has decrypted, in vivo, the molecular signature of atopic dermatitis. The study, conducted in partnership with Prof. Michel Manfait, was published in the journal Experimental Dermatology. Silab's Ad-Resyl, is a purified natural active ingredient that has been specifically developed to prevent the clinical signs of atopic dermatitis and prolong periods of remission following corticosteroid therapy, according to the company. According to Silab, the research studies conducte...